Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Ad-CCL21-DC |
| Trade Name | |
| Synonyms | Autologous dendritic cell-adenovirus CCL21 vaccine |
| Drug Descriptions |
Ad-CCL21-DC is a cancer vaccine comprising dendritic cells engineered to express CCL21, which may enhance antitumor immune response (PMID: 28468947). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C74015 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Ad-CCL21-DC | Ad-CCL21-DC | 0 | 1 |
| Ad-CCL21-DC + Pembrolizumab | Ad-CCL21-DC Pembrolizumab | 0 | 1 |